Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Robert Lustig, MD

Robert Lustig, MD Physician

Director, Network Development Program Professor of Clinical Radiation Oncology

Dr. Lustig is employed by Penn Medicine.

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties

Clinical Expertise:

  • Acoustic Neuroma (Vestibular Schwannoma)
  • Brain Cancer
  • Brain Metastasis
  • Brain Tumors
  • Orbital Tumors
  • Proton Therapy
  • Radiation Oncology - Brain
  • Radiation Treatment
  • Skin Cancer
  • Spinal Cord Cancer
  • Spinal Tumor
  • Thyroid Cancer

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Vetrans Choice Program (6/2018 Not Active)

Education and Training

Medical School: Jefferson Medical College
Residency: Metropolitan Hospital
Residency: Thomas Jefferson University Hospital

Memberships

American Association for Cancer Research (AACR), National American Association for the Advancement of Science (AAAS), National American College of Radiology (ACR), National American Society of Clinical Oncology (ASCO), National American Society of Therapeutic Radiology and Oncology (ASTRO), National Pediatric Proton Foundation, National Radiation Therapy Oncology Group (RTOG), National Society of Neuro-Oncology, National

Hospital Affiliation

Dr. Lustig is employed by Penn Medicine.

Hospital Privileges:

  • Chester County Hospital: Has privileges to treat patients in the hospital.
  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Rathore S, Akbari H, Rozycki M, Abdullah KG, Nasrallah MP, Binder ZA., Davuluri RV, Lustig RA, Dahmane N, Bilello M, O’Rourke D & Davatzikos D: Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1 Scientific Reports 8 (1): 5087,2018.

Rathore S; Akbari H; Doshi J; Shukla G; Rozycki M; Bilello M; Lustig R; Davatzikos C.: Radiomic signature of infiltration in peritumoral edema predicts subsequent recurrence in glioblastoma: implications for personalized radiotherapy planning Journal of Medical Imaging 5 (2): 2018.

Birkhoff, S; Cantrell, M.; Moriarty, H; Lustig, R.: The Usability and Acceptability of a Patient-Centered Mobile Health Tracking App Among a Sample of Adult Radiation Oncology Patients Advances in Nursing Science 00 (00): 1-17,2018.

J. Vogel, S. Both, M. Kirk, C. Hann-Hsiang, R. Bagatell, Y. Li, R. Womer, N. Balamuth, A. Reilly, G. Kurtz, R. Lustig, Z. Touchner, C. Hill-Kayser: Proton Therapy for Pediatric head and neck malignancies Pediactris Blood & Cancer : 2017.

Anamalayil SJ, Teo BK, Lin A, Lustig RA, Ahn PH: Effects of full-neck volumetric-modulated arc therapy vs split-field intensity-modulated head and neck radiation therapy on low neck targets and structures. Br J Radiol 89 (1062): 2016.

Evans SM, Putt, M, Yang XY, Lustig RA, Martinez-Lage M, Williams D, Desai A, Wolf R, Brem S, Koch CJ: Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients. J Neurooncol 127 (2): 391-400,2016.

Sumei Wang, Maria Martinez-Lage, Yu Sakai, Sanjeev Chawla, Sungheon G. Kim, Michelle Alonso-Basanta, Robert A. Lustig, Steven Brem, Suyash Mohan, Ronald L. Wolf, Arati Desai, Harish Poptani: Differentiating Tumor Progression from Pseudo-progression in Patients with Glioblastomas using Diffusion ?Tensor Imaging and Dynamic Susceptibility AJNR AM J Neuroradiol 37 (1): 28-36,2016.

Hill-Kayser CE, Gabriel P, Volz E, Lustig RA, Tochner Z, Hahn SM, Maity A.: Factors Associated with Event Reporting in the Pediatric Radiation Oncology Population Using and Electronic Incident Reporting System. Pract Radiat Oncol 5 (5): 417-422,2015.

Koch C, Lustig R, Xiang-Yang Y, Jenkins W, Wolf R, Martinex-Lage M, Desai A, Dewight W, and Evans, S.: Microvesicles as a Biomarker for Tumor Progression versus Treatment Effect in Radiation/Temozolomide-Treated Glioblastoma Patients. Transl Oncol 7 (6): 752-8,2014.

Maquilan G, Grover S, Alonso-Basanta M, Lustig RA.: Acute toxicity profile of patients with low-grade gliomas and meningiomas receiving proton therapy Am J Clin Oncol 37 (5): 438-43,2014.

Academic Contact Info

Perelman Center for Advanced Medicine
Department of Radiation Oncology
3400 Civic Center Blvd
2nd floor West

Philadelphia, PA 19104
Phone: (215) 349-8429
Patient appointments: 800-789-7366 (PENN)

Related Links